Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Positively charged proteins, also known as cationic proteins, are a broad class of proteins characterized by a high isoelectric point (pI) due to an abundance of basic amino acids such as arginine and lysine [1]. This category includes diverse molecules such as histones, which package DNA, and eosinophil-derived proteins like Eosinophil Cationic Protein (ECP) and Major Basic Protein (MBP), which play roles in the immune response against parasites but can also cause tissue damage in allergic diseases like asthma [2]. Because of their strong positive charge, these proteins interact electrostatically with negatively charged molecules, including cell surface glycosaminoglycans and nucleic acids [3]. In a therapeutic context, polyanionic drugs like heparin are often used to neutralize the toxic effects of certain cationic proteins or to interfere with their biological signaling [4]. However, 'positively charged proteins' is considered a descriptive category rather than a specific, well-defined therapeutic target for drug development [5]. [1] Alberts B, et al. Molecular Biology of the Cell. 4th edition. New York: Garland Science; 2002. [2] Rothenberg ME, Hogan SP. 'The eosinophil.' Annu Rev Immunol. 2006;24:147-74. [3] Xu J, et al. 'Extracellular histones are major mediators of death in sepsis.' Nat Med. 2009;15(11):1318-21. [4] 'Heparin Sodium.' FDA Label / DailyMed. [5] 'Protamine Sulfate.' StatPearls [Internet].
Electrostatic neutralization and sequestration of cationic charges to inhibit biological activity or toxicity.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Positively charged proteins.